Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease

Neuroscience

Volumn 169, Issue 3, 2010, Pages 1347-1363

  Morawski, M ^a   Bruckner G ^a   Jager C ^a   Seeger, G ^a   Arendt, T ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Extracellular matrix; Neurodegeneration; Neurofibrillary tangles; Neuroprotection; Proteoglycans; Tauopathy

Indexed keywords

AGGRECAN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; MEYNERT BASAL NUCLEUS; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NEUROTRANSMISSION; OCULOMOTOR NERVE; PRIORITY JOURNAL; SATELLITE CELL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS;

EID: 77955277116     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.022     Document Type: Article

References (92)

1. Adams I., Brauer K., Arélin C., Härtig W., Fine A., Mäder M., Arendt T., Brückner G. Perineuronal nets in the rhesus monkey and human basal forebrain including basal ganglia. Neuroscience 2001, 108:285-298.
2. Airaksinen M.S., Paetau A., Paljärvi L., Reinikainen K., Riekkkinen P., Suomalainen R., Panula P. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 1991, 44:465-481.
3. Alonso A.D., Zaidi T., Novak M., Barra H.S., Grundke-Iqbal I., Iqbal K. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem 2001, 276(41):37967-37973.
4. Arendt T. Neurodegeneration and plasticity. Int J Dev Neurosci 2004, 22:507-514.
5. Arendt T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 2009, 118:167-179.
6. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol 1983, 61:101-108.
7. Arendt T., Brückner M.K., Gertz H.J., Marcova L. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 1998, 83:991-1002.
8. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991, 1:103-116.
9. Baig S., Wilcock G.K., Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol 2005, 110:393-401.
10. Bamburg J.R., Bloom G.S. Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 2009, 66:635-649.
11. Bonthius D.J., Solodkin A., Van Hoesen G.W. Pathology of the insular cortex in Alzheimer's disease depends on cortical architecture. J Neuropathol Exp Neurol 2005, 64:910-922.
12. Braak E., Braak H., Mandelkow E.M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994, 87:554-567.
13. Braak H., Alafuzzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006, 112:389-404.
14. Braak H., Braak E. Neuropathological staging of Alzheimer's disease. Acta Neuropathol 1991, 82:239-259.
15. Braak H., Braak E. Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 1991, 81:261-268.
16. Brauer K., Härtig W., Gärtner U., Brückner G., Arendt T. Different myelination of rat septohippocampal fibers as revealed by immunofluorescence double-labelling. Brain Res 2000, 878:188-193.
17. Brückner G., Hausen D., Härtig W., Drlicek M., Arendt T., Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 1999, 92:791-805.
18. Brückner G., Morawski M., Arendt T. Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit. Neuroscience 2008, 151:489-504.
19. Carlson S.S., Hockfield S. Central nervous system. Extracellular matrix 1996, Vol. 1:1-23. Harwood Academic, Amsterdam. W.D. Comper (Ed.).
20. Celio M.R. Perineuronal nets of extracellular matrix around parvalbumin-containing neurons of the hippocampus. Hippocampus 1993, 3:55-60.
21. Corcoran J.P., So P.L., Maden M. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 2004, 20:896-902.
22. Dityatev A., Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 2003, 4:456-468.
23. Dudas B., Cornelli U., Lee J.M., Hejna M.J., Walzer M., Lorens S.A., Mervis R.F., Fareed J., Hanin I. Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain. Neurobiol Aging 2002, 23:97-104.
24. Dudas B., Rose M., Cornelli U., Pavlovich A., Hanin I. Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders. Neurodegener Dis 2008, 5:200-205.
25. Evers O., Uylings H.B.M. An optimal antigen retrieval method suitable for different antibodies on human brain tissue stored for several years in formaldehyde fixative. J Neurosci Methods 1997, 72:197-207.
26. Faissner A., Pyka M., Geissler M., Sobik T., Frischknecht R., Gundelfinger E.D., Seidenbecher C. Contributions of astrocytes to synapse formation and maturation-Potential functions of the perisynaptic extracellular matrix. Brain Res Rev 2010, 63:26-38.
27. Fawcett J.W., Curt A. Damage control in the nervous system: rehabilitation in a plastic environment. Nat Med 2009, 15:735-736.
28. Frischknecht R., Heine M., Perrais D., Seidenbecher C., Choquet D., Gundelfinger E.D. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat Neurosci 2009, 12:897-904.
29. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007, 54:1-18.
30. Gaszner B., Korosi A., Palkovits M., Roubos E.W., Kozicz T. Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus. J Comp Neurol 2007, 500:708-719.
31. Gendron T.F., Petrucelli L. The role of tau in neurodegeneration. Mol Neurodegener 2009, 4:1-19.
32. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Ann N Y Acad Sci 1996, 777:121-131.
33. Goedert M., Jakes R., Crowther R.A., Cohen P., Vanmechelen E., Vandermeeren M., Cras P. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994, 301:871-877.
34. Gómez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997, 41:17-24.
35. Grudzien A., Shaw P., Weintraub S., Bigio E., Mash D.C., Mesulam M.M. Locus coeruleus neurobibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 2007, 28:327-335.
36. Härtig W., Brauer K., Brückner G. Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons. Neuroreport 1992, 3:869-872.
37. Härtig W., Brückner G., Brauer K., Schmidt C., Bigl V. Allocation of perineuronal nets and parvalbumin-, calbindin-D28- and glutamic acid decarboxylase-immunoreactivity in the amygdala of the rhesus monkey. Brain Res 1995, 698:265-269.
38. Henny P., Jones B.E. Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. J Comp Neurol 2006, 499:645-661.
39. Hof P.R., Cox K., Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. I. Superior frontal and inferior temporal cortex. J Comp Neurol 1990, 301:44-54.
40. Hof P.R., Cox K., Young W.G., Celio M.R., Rogers J., Morrison J.H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Pathol 1991, 50:451-462.
41. Holt D.J., Graybiel A.M., Saper C.B. Neurochemical architecture of the human striatum. J Comp Neurol 1997, 384:1-25.
42. Horn A.K., Brückner G., Härtig W., Messoudi A. Saccadic omnipause and burst neurons in monkeys and human are ensheathed by perineuronal nets but differ in their expression of calcium-binding proteins. J Comp Neurol 2003, 455:341-352.
43. Horn A.K., Eberhorn A., Härtig W., Ardeleanu P., Messoudi A., Büttner-Ennever J.A. Perioculomotor cell groups in monkey and man defined by their histochemical and functional properties: reappraisal of the Edinger-Westphal nucleus. J Comp Neurol 2008, 507:1317-1335.
44. Hyman B.T., Marzloff K., Wenniger J.J., Dawson T.M., Bredt D.S., Snyder S.H. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann Neurol 1992, 32:818-820.
45. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
46. Iversen L.L., Rossor M.N., Reynolds G.P., Hills R., Roth M., Mountjoy C.Q., Foote S.L., Morrison J.H., Bloom F.E. Loss of pigmented dopamine-β-decarboxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett 1983, 39:95-100.
47. Kromer-Vogt L.J., Hyman B.T., Van Hoesen G.W., Damasio A.R. Pathological alterations in the human amygdala in Alzheimer's disease. Neuroscience 1990, 37:377-385.
48. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24:1121-1159.
49. Lewis D.A., Campbell J.M., Terry R.D., Morrison J.H. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J Neurosci 1987, 7:1799-1808.
50. Mai J.K., Assheuer J., Paxinos G. Atlas of the human brain 2004, Academic Press, San Diego, CA.
51. Marcyniuk N.B., Mann D.M.A., Yates P.O. The topography of cell loss from locus coeruleus in Alzheimer's disease. J Neurol Sci 1986, 76:335-345.
52. Marcyniuk N.B., Mann D.M.A., Yates P.O. Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci Lett 1986, 64:247-252.
53. McKhann G., Drachmann D., Folstein M., Katzmann R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of Health and Human Service Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
54. McRae P., Rocco M.M., Kelly G., Brumberg J.C., Matthews R.T. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J Neurosci 2007, 27:5405-5413.
55. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999, 24:521-529.
56. Mesulam M., Shaw P., Mash D., Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 2004, 55:815-828.
57. Miyata S., Nishimura Y., Nakashima T. Perineuronal nets protect against amyloid β-protein neurotoxicity in cultured cortical neurons. Brain Res 2007, 1150:200-206.
58. Morawski M., Brückner M.K., Riederer P., Brückner G., Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp Neurol 2004, 188:309-315.
59. Morawski M., Brückner G., Jäger C., Seeger G., Künzle H., Arendt T. Aggrecan-based extracellular matrix shows unique cortical features and conserved subcortical principles of mammalian brain organization in the Madagascan lesser hedgehog tenrec (Echinops telfairi Martin, 1838). Neuroscience 2010, 165:831-849.
60. Morawski M., Pavlica S., Seeger G., Grosche J., Kouznetsova E., Schliebs S., Brückner G., Arendt T. Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. Neurobiol Aging 2010, 31:1254-1256.
61. Morel A., Magnin M., Jeanmonod D. Multiarchitectonic and stereotactic atlas of the human thalamus. J Comp Neurol 1997, 387:588-630.
62. Morris N.P., Henderson Z. Perineuronal nets ensheath fast spiking, parvalbumin-immunoreactive neurons in the medial septum/diagonal band complex. Eur J Neurosci 2000, 12:828-838.
63. Mufson E.J., Ginsberg S.D., Ikonomovic M.D., deKosky S.T. Human cholinergic basal forebrain: chemoanatomy and neurological dysfunction. J Chem Neuroanat 2003, 26:233-242.
64. Münkle M.C., Waldvogel H.J., Faull R.L.M. The distribution of calbindin, calretinin, and parvalbumin immunoreactivity in the human thalamus. J Chem Neuroanat 2000, 19:155-173.
65. Murakami T., Ohtsuka A. Perisynaptic barrier of proteoglycans in the mature brain and spinal cord. Arch Histol Cytol 2003, 66:195-207.
66. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomamillary nucleus of patients with Alzheimer's disease. Neurosci Lett 1993, 151:196-199.
67. Okamoto M., Mori S., Ichimura M., Endo H. Chondroitin sulfate proteoglycans protect cultured rat's cortical and hippocampal neurons from delayed cell death induced by excitatory amino acids. Neurosci Lett 1994, 172:51-54.
68. Pantazopoulos H., Lange N., Hassinger L., Beretta S. Subpopulations of neurons expressing parvalbumin in the human amygdala. J Comp Neurol 2006, 496:706-722.
69. Pantazopoulos H., Murray E.A., Beretta S. Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala. Brain Res 2008, 1207:84-95.
70. Parvizi J., Van Hoesen G.W., Damasio A. Severe pathological changes of parabrachial nucleus in Alzheimer's disease. Neuroreport 1998, 9:4151-4154.
71. Parvizi J., Van Hoesen G.W., Damasio A. The selective vulnerability of brain stem nuclei to Alzheimer's disease. Ann Neurol 2001, 49:53-66.
72. Paxinos G., Huang X.F., Toga A.W. The rhesus monkey brain in stereotaxic coordinates 2000, Academic Press, San Diego, CA.
73. Perl D.P. Neuropathology of Alzheimer's disease. Mt Sinai J Med 2010, 77:32-42.
74. Porzig R., Singer D., Hoffmann R. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun 2007, 358:644-649.
75. Rauch U. Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci 2004, 61:2031-2045.
76. Rüb U., Del Tredici K., Schultz C., Büttner-Ennever J.A., Braak H. The premotor region essential for rapid vertical eye movements shows early involvement in Alzheimer's disease-related cytoskeletal pathology. Vis Res 2001, 41:2149-2156.
77. Rüb U., Del Tredici K., Schultz C., Thal D.R., Braak E., Braak H. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol 2000, 26:553-567.
78. Rüb U., Del Tredici K., Schultz C., Thal D.R., Braak E., Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol 2001, 101:555-564.
79. Saper C.B., Chelimsky C.T. A cytoarchitectonic and histochemical study of nucleus basalis and associated cell groups in the normal human brain. Neuroscience 1984, 13:1023-1037.
80. Saper C.B., German D.C. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 1987, 74:364-370.
81. Smeets W.J., Gonzalez A. Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach. Brain Res Rev 2000, 33:308-379.
82. Sorvari H., Soininen H., Paljärvi L., Karkola K., Pitkänen A. Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complex. J Comp Neurol 1995, 360:185-212.
83. Van Hoesen G.W., Hyman B.T. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 1990, 83:445-457.
84. Virgintino D., Perissinotto D., Girolamo F., Mucignat M.T., Montanini L., Errede M., Kaneiwa T., Yamada S., Sugahara K., Roncali L., Perris R. Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex. J Cell Mol Med 2009, 13:3151-3173.
85. BR2 receptor subunits. J Comp Neurol 2004, 470:339-356.
86. Walker L.C., Price D.L., Young W.S. GABAergic neurons in the primate basal forebrain magnocellular complex. Brain Res 1989, 499:188-192.
87. Washburn C.P., Sirois J.E., Talley E.M., Guyenet P.G., Bayliss D.A. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. J Neurosci 2002, 22:1256-1265.
88. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482-497.
89. Wu F., Lee S., Schumacher M., Jun A., Chakravarti S. Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon. Exp Eye Res 2008, 87:214-225.
90. Yamaguchi Y. Chondroitin sulfate proteoglycans in the nervous system. Proteoglycans. Structure, biology, and molecular interactions 2000, 379-402. Marcel Decker, New York, NY. R.V. Iozzo (Ed.).
91. Yasuhara O., Akiyama H., McGeer E., McGeer O.L. Immunohistochemical localization of hyaluronic acid in rat and human brain. Brain Res 1994, 635:269-282.
92. Zimmermann D.R., Dours-Zimmermann M.T. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol 2008, 130:635-653.